Click for new scientific resources and news about Corona[COVID-19]

Paper Information

Journal:   IRANIAN JOURNAL OF MEDICAL SCIENCES (IJMS)   MARCH 2008 , Volume 33 , Number 1; Page(s) 12 To 16.
 
Paper: 

COMBINED TREATMENT WITH OXYBUTYNIN AND IMIPRAMINE IN ENURESIS

 
 
Author(s):  ESMAEILI MOHAMMAD*, ESMAEILI MARJAN
 
* DEPARTMENT OF PEDIATRIC NEPHROLOGY, GHAEM MEDICAL CENTER, MASHHAD UNIVERSITY OF MEDICAL SCIENCES, MASHHAD, IRAN
 
Abstract: 

Background: Primary nocturnal enuresis is a common disorder that often leads to considerable distress in affected children and their family. In many countries pharmacologic therapy is preferred to non-pharmacologic behavioral and conditional alarm therapy. Imipramine, oxybutynin, and desmopressin have been used for enuresis with various efficacies. The aim of the present study was to compare the efficacy of imipramine, oxybutynin, and combined imipramine and oxybutynin in enuretic children aged 6-14 years old.

Methods: In a randomized controlled study 89 primary enuretic children who were otherwise normal were allocated to three groups: group A (imipramine users, n=29), group B (oxybutynin users, n=26), and group C (combined imipramine and oxybutynin users, n=34). The number of wet nights per week during control period (2 weeks prior treatment), and treatment period (I month) were compared in each group and inter groups. Also the cure rate in the treatment period and the relapse rate in the follow up period (I month) were compared between the three groups.

Results: The mean ages in groups A, B, and C were 7.9±1.1.1years, 8.2±1.6 years, and 8.2±1.4 years respectively. There was no significant difference in the mean ages in the three groups (P=0.53). In each group the mean number of wet nights per week decreased during treatment period compared with pretreatment period. This reduction was statistically significant (P<0.001) in each group). Efficacy of treatment between the three groups was compared. There was significant difference between them (P<0.001), but there was no significant difference between group A, and group B (P=0.56). The cure rate during treatment period was 13.7%, 23%, and 41% in groups A, B, and C respectively. This difference was statistically significant (P=0.04). The relapse rate during follow up period in groups A, B, and C was 58.6%, 42.3% and 20.5% respectively, revealing statistical significance (P=0.008) No significant adverse effects for the medications were observed.
Conclusion: Our findings suggest that combined imipramine and oxybuty.nin for primary enuresis is more effective than either drug used alone. The combined therapy is recommended in enuretic children who are non-responsive to imipramine or oxybutynin' alone.
 
Keyword(s): ENURESIS, IMIPRAMINE, OXYBUTYNIN
 
 
References: 
  • Not Registered.
  •  
  •  
 
Citations: 
  • Not Registered.
 
+ Click to Cite.
APA: Copy

ESMAEILI, M., & ESMAEILI, M. (2008). COMBINED TREATMENT WITH OXYBUTYNIN AND IMIPRAMINE IN ENURESIS. IRANIAN JOURNAL OF MEDICAL SCIENCES (IJMS), 33(1), 12-16. https://www.sid.ir/en/journal/ViewPaper.aspx?id=106525



Vancouver: Copy

ESMAEILI MOHAMMAD, ESMAEILI MARJAN. COMBINED TREATMENT WITH OXYBUTYNIN AND IMIPRAMINE IN ENURESIS. IRANIAN JOURNAL OF MEDICAL SCIENCES (IJMS). 2008 [cited 2021July25];33(1):12-16. Available from: https://www.sid.ir/en/journal/ViewPaper.aspx?id=106525



IEEE: Copy

ESMAEILI, M., ESMAEILI, M., 2008. COMBINED TREATMENT WITH OXYBUTYNIN AND IMIPRAMINE IN ENURESIS. IRANIAN JOURNAL OF MEDICAL SCIENCES (IJMS), [online] 33(1), pp.12-16. Available: https://www.sid.ir/en/journal/ViewPaper.aspx?id=106525.



 
  pdf-File
Yearly Visit 41
 
 
Latest on Blog
Enter SID Blog